Ecuador vs Fiji: New cases tested for RR-/MDR-TB
Ecuador
100.0%
in 2024
Fiji
100.0%
in 2024
Ecuador rank
1st
Fiji rank
1st
New cases tested for RR-/MDR-TB over time
- Ecuador
- Fiji
How they compare
Ecuador currently reports 100.0% against 100.0% in Fiji, a difference of 0.0%.
The two have swapped places 5 times across 14 shared years of data; in 2007 it was Ecuador ahead.
Ecuador ranks 1st and Fiji ranks 1st of 192 countries.
Across the 3 decades both report, Ecuador averaged higher in 2 and Fiji in 1.
Head to head by decade
| Decade | Ecuador | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.0% | 3.5% | 0.5% | Ecuador |
| 2010s | 21.7% | 35.0% | 13.3% | Fiji |
| 2020s | 95.8% | 79.2% | 16.6% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Ecuador or Fiji?
- Ecuador, at 100.0% against 100.0% in Fiji as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Ecuador and Fiji?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Fiji?
- 14 years are reported by both, from 2007 to 2024.
- How do Ecuador and Fiji rank globally for new cases tested for rr-/mdr-tb?
- Ecuador ranks 1st and Fiji ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.